Psoriasis

Case 2: Patient and Provider Educational Needs
November 15, 2022

Dr Mark Lebwohl provides insight into the educational needs of both patients and providers surround the utilization of spesolimab and its importance in the management of patients with generalized pustular psoriasis.

Case 2: Changing the Treatment Paradigm
November 15, 2022

Mark G. Lebwohl, MD, comments on the clinical implications of the recent approval of spesolimab for the treatment of generalized pustular psoriasis.

Case 2: 64-Year-Old Female With a Long History of Plaque Psoriasis
November 15, 2022

An expert in dermatology presents the case of a 64-year-old female with a long history of plaque psoriasis, focusing on her disease severity and age-related management considerations.

Managing Candidiasis Associated With IL-17 Inhibitors in Plaque Psoriasis
November 14, 2022

Expert dermatologists discuss the risk of candidiasis with IL-17 inhibitors when managing plaque psoriasis and how to manage candidiasis.

Using Bimekizumab to Manage Plaque Psoriasis
November 14, 2022

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss the novel mechanism of bimekizumab and how it can change the treatment landscape for plaque psoriasis.

Case 1: Treatment and Disease Management Goals
November 08, 2022

Goals of generalized pustular psoriasis treatment are reviewed by Dr Mark Lebwohl, where he comments on the need to consider patient disease severity and comorbidities.

Case 1: Treatment and Disease Management Challenges
November 08, 2022

Dr Mark Lebwohl comments on the treatment and management considerations for a patient suffering from severe generalized pustular psoriasis, highlighting the inefficiency of systemic steroids in the management of this condition.

Case 1: 28-Year-Old Female Patient With Psoriasis
November 08, 2022

Mark G. Lebwohl, MD, introduces the case of a 28-year-old female nurse with a long history of psoriasis, commenting on her past medical history and initial presentation.

Role of IL-17 Inhibitor Durability in Plaque Psoriasis
November 07, 2022

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss the durability of IL-17 inhibitors in managing plaque psoriasis.

Approaching Plaque Psoriasis Treatment Based on Comorbidities
November 07, 2022

Expert dermatologists discuss how to select treatment for plaque psoriasis while taking comorbidities into consideration.